Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

146.12
+2.681.87%
Post-market: 146.120.00000.00%19:56 EDT
Volume:5.38M
Turnover:787.47M
Market Cap:181.29B
PE:-55.88
High:147.91
Open:144.52
Low:143.50
Close:143.44
52wk High:157.29
52wk Low:108.46
Shares:1.24B
Float Shares:1.24B
Volume Ratio:1.00
T/O Rate:0.43%
Dividend:3.22
Dividend Rate:2.20%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.33
PE(LYR):21.55

Loading ...

Rani Therapeutics Names Michelle Gilson to Board as Audit Committee Chair

Reuters
·
Aug 04

Gilead update on California ruling removes an overhang, says UBS

TIPRANKS
·
Aug 04

California Supreme Court Rules for Gilead in TDF Litigation

Reuters
·
Aug 04

California Supreme Court Rules in Favor of Gilead Sciences in 'Duty to Innovate' Case Involving Hiv Drugs

THOMSON REUTERS
·
Aug 04

Gilead’s GS-2426 Phase 1 Trial Targets MTAP-Deleted Tumors: What Investors Should Know

TIPRANKS
·
Aug 04

Eli Lilly Could Swing Over $76 Billion In Value After Earnings

Benzinga_recent_news
·
Aug 03

Compugen Publishes Corporate Presentation on AI-Driven Immuno-Oncology Antibody Pipeline

Reuters
·
Aug 03

Israel's Compugen Q2 Revenue More than Doubles, Net Loss Narrows

Reuters
·
Aug 03

Compugen Q2 FY26 Net Loss Narrows to USD 7 Million; Revenue More than Doubled to USD 2.6 Million

Reuters
·
Aug 03

Moderna Inc. Stock Slips 5.4%, Underperforms Peers

Dow Jones
·
Aug 01

Gilead Sciences Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 31

Gilead’s Twice-Yearly HIV Strategy: What the New Phase 3 Study Means for Investors

TIPRANKS
·
Jul 31

Movement Alert|Gilead Sciences Falls 3.02% in Regular Trading, Biotech Sector Broad Selloff Triggers Technical Pullback

Market Focus
·
Jul 30

Analysts Conflicted on These Healthcare Names: Biogen (BIIB), NeuroPace (NPCE) and Gilead Sciences (GILD)

TIPRANKS
·
Jul 30

Gilead price target lowered to $145 from $155 at Barclays

TIPRANKS
·
Jul 29

Movement Alert|Gilead Sciences Overnight Rise 3.46%, Earnings Expectations and Oncology Pipeline Catalysts Drive Momentum

Market Focus
·
Jul 29

Earning Preview: Gilead Sciences revenue is expected to increase by 6.13%, and institutional views are bullish

Earnings Agent
·
Jul 29

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Movement Alert|Gilead Sciences Rises 3.13% in Regular Trading, Biotech Sector Rally and Earnings Optimism Fuel Gains

Market Focus
·
Jul 28

Barclays Adjusts Gilead Sciences Price Target to $145 From $155, Maintains Equalweight Rating

MT Newswires Live
·
Jul 28